XML 41 R33.htm IDEA: XBRL DOCUMENT v3.22.2
STOCKHOLDERS EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 07, 2020
Feb. 28, 2022
Dec. 31, 2021
Nov. 30, 2021
Oct. 28, 2020
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Sep. 30, 2021
Common stock shares                 1,400,000  
Offering price             $ 22.62   $ 22.62  
Aggregate net proceeds                 $ 29,400,000  
Additional net proceeds                 $ 4,400,000  
Additional shares of common stock                 210,000  
Fair value of common stock             $ 36,000   $ 111,500  
Proceeds from issuance of common stock             800,000   1,400,000  
Proceeds from issuance of common stock               $ 0 47,363,426  
Series HH [Member]                    
Warrants exercised   200                
Exercise Price   $ 3.13                
Consulting Agreements [Member]                    
Total expense           $ 201,000 $ 403,000 603,000 $ 956,000  
Consulting fees inclued prepaid expenses           $ 221,000   $ 221,000   $ 364,000
December 2020 [Member]                    
Common stock shares                 1,000,000  
Offering price             $ 14.65   $ 14.65  
Proceeds from issuance of common stock                 $ 13,600,000  
Consultants [Member]                    
Exercise price               $ 11.61    
Expiration date               November 17, 2022    
Aggregate Option Fair Value               $ 28,000    
Options issued               5,000    
Consultants [Member] | Restricted Stock [Member]                    
Weighted average grant date fair value           $ 3.52 $ 23.39 $ 5.40 $ 19.47  
Common stock issued for service, shares           38,287 13,184 81,782 41,714  
Consultants One [Member]                    
Options issued               15,000    
Series X [Member]                    
Expiration date               7/13/2024    
Incremental cost           $ 294,000 $ 351,000 $ 294,000 $ 265,000  
Expiration date description the expiration dates of the Series N, Series X, Series Y and Series UU warrants were extended one year                  
Series Y [Member]                    
Expiration date               8/15/2024    
Incremental cost           $ 635,000 $ 103,000 $ 635,000 $ 62,000  
Expiration date description the expiration dates of the Series N, Series X, Series Y and Series UU warrants were extended one year                  
Series NN [Member]                    
Warrants exercised               10,000    
Exercise Price Of Warrants Exercised               $ 2.52    
Proceeds from warrants exercised               $ 25,200    
Exercise Price             $ 2.52   $ 2.52  
Expiration date               7/24/2024    
Series Z [Member]                    
Warrants exercised       184,800            
Exercise Price       $ 13.75     0   13.75  
Series AA [Member]                    
Warrants exercised   100,000                
Exercise Price   $ 13.75         0   13.75  
Series CC [Member]                    
Warrants exercised     640         15,205    
Proceeds from warrants exercised               $ 76,025    
Exercise price per share     $ 5.00         $ 5.00    
Exercise Price             $ 5.00   $ 5.00  
Series UU warrants [Member]                    
Expiration date description the expiration dates of the Series N, Series X, Series Y and Series UU warrants were extended one year                  
Series N Warrants [Member]                    
Incremental cost             $ 351,000   $ 265,000  
Expiration date description the expiration dates of the Series N, Series X, Series Y and Series UU warrants were extended one year                  
Non-Qualified Stock Option Plans [Member]                    
Total Shares Reserved Under Plans           2,000,000        
Grant performance-based stock options               250,000    
Common stock price             $ 10.48   $ 10.48  
Stock options vest             100.00%   100.00%  
Series W Warrants [Member]                    
Warrants exercised         688,930          
Exercise Price         $ 16.75